IRIS PubliCatt

Rocca, Bianca
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 3.870
NA - Nord America 3.789
AS - Asia 770
SA - Sud America 56
AF - Africa 50
OC - Oceania 30
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.567
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.754
DE - Germania 1.127
SE - Svezia 777
CN - Cina 508
UA - Ucraina 503
IT - Italia 433
IE - Irlanda 281
FR - Francia 246
GB - Regno Unito 123
PL - Polonia 112
FI - Finlandia 109
IN - India 85
TR - Turchia 63
ES - Italia 31
AU - Australia 28
RU - Federazione Russa 28
BE - Belgio 26
IR - Iran 23
CI - Costa d'Avorio 22
AR - Argentina 18
CA - Canada 18
HK - Hong Kong 18
JP - Giappone 17
MX - Messico 17
NL - Olanda 16
BR - Brasile 14
CH - Svizzera 12
ET - Etiopia 12
KR - Corea 11
CO - Colombia 10
AT - Austria 9
PH - Filippine 7
MK - Macedonia 6
CL - Cile 5
CZ - Repubblica Ceca 5
GR - Grecia 5
PE - Perù 5
SG - Singapore 5
ZA - Sudafrica 5
EG - Egitto 4
GH - Ghana 4
IL - Israele 4
NO - Norvegia 4
RO - Romania 4
VN - Vietnam 4
DK - Danimarca 3
ID - Indonesia 3
IQ - Iraq 3
MT - Malta 3
PK - Pakistan 3
PT - Portogallo 3
TW - Taiwan 3
BJ - Benin 2
KW - Kuwait 2
LT - Lituania 2
NZ - Nuova Zelanda 2
VE - Venezuela 2
YE - Yemen 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AZ - Azerbaigian 1
BO - Bolivia 1
EC - Ecuador 1
EU - Europa 1
KE - Kenya 1
LV - Lettonia 1
MM - Myanmar 1
MO - Macao, regione amministrativa speciale della Cina 1
QA - Qatar 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
TJ - Tagikistan 1
Totale 8.567
Salva come PNG Salva come JPEG
Città #
Chandler 658
Ashburn 463
Dublin 275
Jacksonville 255
San Mateo 225
Wilmington 163
Nanjing 151
Woodbridge 120
Ann Arbor 106
Warsaw 105
Houston 93
Lawrence 92
Cattolica 88
Boston 80
Dearborn 71
Milan 71
Fairfield 70
Beijing 69
New York 62
Rome 62
Nürnberg 59
Redwood City 59
Princeton 53
Seattle 52
Izmir 46
Nanchang 38
Chicago 33
Los Angeles 33
Mountain View 32
Shenyang 32
Tianjin 29
University Park 26
Redmond 25
Hebei 24
Boardman 23
Bremen 23
Hangzhou 23
Zhengzhou 23
Abidjan 22
Kunming 22
Pune 20
Detroit 19
Brussels 18
Shanghai 18
Bareggio 17
Cambridge 17
Federal 16
Hounslow 16
Mexico 16
Tobarra 16
Wayne 16
Fremont 15
Leawood 15
Marseille 15
Augusta 14
Busto Arsizio 14
Norwalk 14
Washington 13
Hong Kong 12
Jiaxing 12
Lancaster 10
Simi Valley 10
Andover 9
Changsha 9
Falls Church 9
Lanzhou 8
Bursa 7
Edinburgh 7
Guangzhou 7
Munich 7
Quezon City 7
Vienna 7
Ardabil 6
Hefei 6
Helsinki 6
Kish 6
Kraków 6
Latham 6
London 6
Prilep 6
Araucária 5
Bogotá 5
Catania 5
Chieti 5
Gurgaon 5
Indiana 5
Toronto 5
Accra 4
Atlanta 4
Bern 4
Cape Town 4
Central 4
Changchun 4
Jinan 4
Lima 4
North York 4
Nuremberg 4
Ottawa 4
Philadelphia 4
Santiago 4
Totale 4.501
Salva come PNG Salva come JPEG
Nome #
Qualitative and quantitative modifications of von willebrand factor in patients with essential thrombocythemia and controlled platelet count 262
More, more, more: Reducing thrombosis in acute coronary syndromes beyond dual antiplatelet therapy-current data and future directions 247
Association of congenital protein C deficiency and latent myeloproliferative disease as cause of splanchnic venous thrombosis in a 34-year-old woman 225
Mean Platelet Volume, Platelet Distribution Width, and Platelet Count in Type 2 Diabetes Mellitus, Impaired Fasting Glucose, and Metabolic Syndrome: systematic review and meta-analysis 141
Obesity is associated with in vivo platelet activation and impaired responsiveness to once-daily, low-dose aspirin 134
Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study. 132
The recovery of platelet cyclooxygenase activity explains interindividual variability in responsiveness to low-dose aspirin in patients with and without diabetes 122
Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study 114
Prostaglandin E2 differentially modulates human platelet function through the prostanoid EP2 and EP3 receptors 113
Formation of methionine sulfoxide by peroxynitrite at position 1606 of von Willebrand factor inhibits its cleavage by ADAMTS-13. A new prothrombotic mechanism associated with oxidative stress 110
Aspirin-insensitive thromboxane biosynthesis in essential thrombocythemia is explained by accelerated renewal of the drug target 108
In vivo platelet activation and aspirin responsiveness in type 1 diabetes mellitus 106
Effect of fibrinogen concentration on the velocity of platelet aggregation. 102
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 99
Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient mice 98
Pseudo-acquired vWD in essential thrombocythemia: the role of platelets 96
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy 96
In Vivo Platelet Activation and Aspirin Responsiveness in Type 1 Diabetes 95
Platelet mean volume, distribution width, and count in type 2 diabetes, impaired fasting glucose, and metabolic syndrome: a meta-analysis 91
A randomized, double-blind trial of three aspirin regimens to optimize antiplatelet therapy in essential thrombocythemia 86
Evidence for a founder effect of the MPL-S505N mutation in eight Italian pedigrees with hereditary thrombocythemia 85
Increased thromboxane biosynthesis in essential thrombocythemia. 83
Safety of Antithrombotic Agents in Elderly Patients with Acute Coronary Syndromes 82
Aspirin, stroke and drug-drug interactions 80
Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis 78
Drug insight: aspirin resistance- fact or fashion 77
Fechtner syndrome: report of a third family and literature review 76
Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo" 76
Patient-independent variables affecting the assessment of aspirin responsiveness by serum thromboxane measurement 76
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis 75
Antiplatelet Agents for the Treatment and Prevention of Coronary Atherothrombosis. 75
Antithrombotic therapy in atrial fibrillation associated with valvular heart disease: A joint consensus document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) 74
Type 2 Diabetes, Obesity, and Aspirin Responsiveness* 73
Aspirin: promise and resistance in the new millennium. 72
Homocysteinemia is inversely correlated with platelet count and inversely correlated with sE-and sP-selectin levels in females homozygous for C677T methylenetetrahydrofolate reductase 70
In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythaemia 70
Farmaci antipiastinici 69
The future of antiplatelet therapy in cardiovascular disease 68
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 67
Bleeding and thrombosis in myeloproliferative disorders: mechanisms and treatment 66
The Aspirin Regimens in Essential Thrombocythemia (ARES) phase II randomized trial design: Implementation of the serum thromboxane B(2) assay as an evaluation tool of different aspirin dosing regimens in the clinical setting 65
Inherited macrothrombocytopenia with distinctive platelet ultrastructural and functional features 62
Another family with IGPS 62
Cystic fibrosis transmembrane conductance regulator (CFTR) expression in human platelets: impact on mediators and mechanisms of the inflammatory response 62
In vivo prostacyclin biosynthesis and effects of different aspirin regimens in patients with essential thrombocythemia 62
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector. 61
Platelet progenitors: the hidden drug target 61
Stability of urinary thromboxane A2 metabolites and adaptation of the extraction method to small urine volume 60
2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD 60
The contribution of cyclooxygenase-1 and -2 to persistent thromboxane biosynthesis in aspirin-treated essential thrombocythemia: implications for antiplatelet therapy 59
Identifying determinants of variability to tailor aspirin therapy 59
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter 58
Platelet indices and glucose control in type 1 and type 2 diabetes mellitus: A case-control study 58
Eicosanoid biosynthesis and metabolism in myeloproliferative disorders 57
Plasma protein oxidation is associated with an increase of procoagulant markers causing an imbalance between pro- and anticoagulant pathways in healthy subjects 57
Management of antithrombotic therapy after bleeding in patients with coronary artery disease and/or atrial fibrillation: expert consensus paper of the European Society of Cardiology Working Group on Thrombosis 56
Familial autoimmune myasthenia gravis with different pathogenetic antibodies 55
Wiskott-Aldrich syndrome: report of an autosomal dominant variant 55
Aspirin inhibits cancer stem cells properties and growth of glioblastoma multiforme through Rb1 pathway modulation 54
In vivo thromboxane-dependent platelet activation is persistently enhanced in subjects with impaired glucose tolerance 54
Aspirin in the primary prevention of cardiovascular disease in diabetes mellitus: A new perspective 54
Circulating endothelial progenitor cells and residual in vivo thromboxane biosynthesis in low-dose aspirin-treated polycythemia vera patients 53
Determinants of the interindividual variability in response to antiplatelet drugs. 53
Antithrombotic therapy in the elderly: expert position paper of the European Society of Cardiology Working Group on Thrombosis 53
Management of antithrombotic therapy in patients undergoing transcatheter aortic valve implantation: a consensus document of the ESC Working Group on Thrombosis and the European Association of Percutaneous Cardiovascular Interventions (EAPCI), in collaboration with the ESC Council on Valvular Heart Disease 53
Successful pregnancy in a living-related kidney transplant recipient who received sirolimus throughout the whole gestation. 52
The linkage between binding of the C-terminal domain of hirudin and amidase activity in human alpha-thrombin 52
MYH9 spectrum of autosomal-dominant giant platelet syndromes: unexpected association with fibulin-1 variant-D inactivation 51
Association of Platelet Thromboxane Inhibition by Low-Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia 51
Increased thromboxane metabolites excretion in liver cirrhosis. 50
A case of coloboma in a newborn to a woman taking mycophenolate mofetil in pregnancy after kidney transplantation. 49
Nonsteroidal antiinflammatory drugs: past, present and future 49
Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter 49
Fibrinogen-elongated gamma chain inhibits thrombin-induced platelet response, hindering the interaction with different receptors 48
Antithrombotic Therapy in Atrial Fibrillation Associated with Valvular Heart Disease: Executive Summary of a Joint Consensus Document from the European Heart Rhythm Association (EHRA) and European Society of Cardiology Working Group on Thrombosis, Endorsed by the ESC Working Group on Valvular Heart Disease, Cardiac Arrhythmia Society of Southern Africa (CASSA), Heart Rhythm Society (HRS), Asia Pacific Heart Rhythm Society (APHRS), South African Heart (SA Heart) Association and Sociedad Latinoamericana de Estimulación Cardíaca y Electrofisiología (SOLEACE) 48
On-pump Cardiac Surgery Enhances Platelet Renewal and Impairs Aspirin Pharmacodynamics: Effects of Improved Dosing Regimens 48
Antithrombotic therapy in diabetes: which, when, and for how long? 48
Autosomal dominant giant platelet syndrome: a hint of the same genetic defect as in Fetchner syndrome owing to a similar genetic linkage to chromosome 22q11-13 47
Platelet activation and inhibition in polycythemia vera and essential thrombocythemia. 47
Interindividual Variability in response to aspirin and P2Y12 blockers in patients at high cardiovascular risk-the state of the evidence 46
The lifespan determinant p66sch drives obesity-induced oxidative stress, mitochondrial dysfunction and vascular inflammation 45
Unmet clinical needs of antithrombotic treatment in Philadelphia negative myeloproliferative neoplasms 45
Should patients with osteoarthritis be treated with COX2 inhibitors rather than traditional NSAIDs? 45
Lipid and protein oxidation contribute to a prothrombotic state in patients with type 2 diabetes mellitus. 44
Role of prostacyclin in the cardiovascular response to thromboxane A2 44
Aspirin and Other COX-1 Inhibitors 44
Farmaci Antipiastrinici 44
The Key Contribution Of Platelet And Vascular Arachidonic Acid Metabolism To The Pathophysiology Of Atherothrombosis 44
Antithrombotic therapy in patients with acute coronary syndrome complicated by cardiogenic shock or out-of-hospital cardiac arrest: a Joint Position Paper from the European Society of Cardiology (ESC) Working Group on Thrombosis, in association with the Acute Cardiovascular Care Association (ACCA) and European Association of Percutaneous Cardiovascular Interventions (EAPCI) 44
Effect of ketorolac, ketoprofen and nefopam on platelet function 43
Pathophysiology of Thrombosis in Peripheral Artery Disease 42
MYH9-related disease: May-Hegglin anomaly, Sebastian syndrome, Fechtner syndrome, and Epstein syndrome are not distinct entities but represent a variable expression of a single illness 41
Antithrombotic therapy and revascularisation strategies in people with diabetes and coronary artery disease 41
LACK OF AN ASSOCIATION BETWEEN INHERITED THROMBOPHILIC RISK FACTORS AND IDIOPATIC SUDDEN SENSORINEURAL HEARING LOSS IN ITALIAN PATIENTS 41
Frailty in cardiology: definition, assessment and clinical implications for general cardiology. A consensus document of the Council for Cardiology Practice (CCP), Acute Cardiovascular Care Association (ACCA), Association of Cardiovascular Nursing and Allied Professions (ACNAP), European Association of Preventive Cardiology (EAPC), European Heart Rhythm Association (EHRA), Council on Valvular Heart Diseases (VHD), Council on Hypertension (CHT), Council of Cardio-Oncology (CCO), Working Group (WG) Aorta and Peripheral Vascular Diseases, WG e-Cardiology, WG Thrombosis, of the European Society of Cardiology, European Primary Care Cardiology Society (EPCCS) 41
Aspirin, 110 years later 40
Variability in the Responsiveness to Low-Dose Aspirin: Pharmacological and Disease-Related Mechanisms. 39
Impact of COX-2 deletion on platelet and megakaryocyte phenotypes 39
genetic deletion of P66 (sch) protects against obesity induced mithocondrial dysfunction, oxidative stress and vascular inflammation 39
Very-low-dose twice-daily aspirin maintains platelet inhibition and improves haemostasis during dual-antiplatelet therapy for acute coronary syndrome 39
Totale 7.091
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.289
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.289
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019176 0 0 0 0 0 0 0 0 0 0 111 65
2019/20201.241 277 52 114 134 61 84 97 41 51 74 138 118
2020/20211.038 43 113 24 108 149 54 115 27 140 50 181 34
2021/20221.145 157 93 13 73 86 32 32 187 44 33 175 220
2022/20232.133 313 301 176 241 175 237 75 172 257 43 95 48
2023/20241.047 43 348 42 179 80 132 97 29 28 69 0 0
Totale 8.717